Neuren Pharmaceuticals | NEU - Interest Expense On Debt


Neuren Pharmaceuticals reported AUD0 in Interest Expense on Debt for its fiscal semester ending in June of 2024.





Interest Expense On Debt Change Date
Akebia Therapeutics 349.66M 12.86M Jun/2026
Alaunos Therapeutics USD 1.07M 215K Jun/2023
Avita Medical AUD 1.25M 100K Jun/2025
Clinuvel Pharmaceuticals AUD 2.49M 51.97K Jun/2025
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Genetic Signatures AUD 18K 17K Jun/2024
Ionis Pharmaceuticals USD 18M 1000K Jun/2026
Medical Developments International AUD 18K 3K Jun/2025
Neuren Pharmaceuticals AUD 0 0 Jun/2024
Organon & Co USD 108M 3M Jun/2026
PYC Therapeutics AUD 17K 11K Jun/2025
Tectonic Therapeutic USD 246.58M 246.56M Mar/2026
Telix Pharmaceuticals AUD 19.39M 11.77M Jun/2026
Viatris USD 120.7M 600K Jun/2026
Xeris Pharmaceuticals USD 6.88M 269K Mar/2026